Relationship of endothelial function and atherosclerosis to treatment response in late-life depression

International Journal of Geriatric Psychiatry

Volumn 27, Issue 9, 2012, Pages 967-973

  Paranthaman, R ^a   Greenstein, A ^b   Burns, A S ^b   Heagerty, A M ^b   Malik, R A ^b   Baldwin, R C ^c  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

atherosclerosis; depression; endothelial function; mood disorders; old age; treatment response

Indexed keywords

ACETYLCHOLINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LATE LIFE DEPRESSION; MALE; MONOTHERAPY; TREATMENT RESPONSE; VASCULAR RESISTANCE; VASODILATATION;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ARTERIES; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE;

EID: 84864649537     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2811     Document Type: Article

References (37)

1. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ,. 1987. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation - contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 61 (2): 181-186.
2. Aizenstein HJ, Nebes RD, Meltzer CC, et al,. 2002. The relation of white matter hyperintensities to implicit learning in healthy older adults. Int J Geriatr Psychiatry 17 (7): 664-669.
3. Alexopoulos GS,. 2006. The vascular depression hypothesis: 10 years later. Biol Psychiatry 60 (12): 1304-1305.
4. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al,. 2008. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 165 (2): 238-244.
5. Baldwin R, Jeffries S, Jackson A, et al,. 2004. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 34 (1): 125-136.
6. Baldwin RC,. 2005. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int J Geriatr Psychiatry 20 (1): 1-11.
7. Baldwin RC, Gallagley A, Gourlay M, Jackson A, Burns A,. 2006. Prognosis of late life depression: a three-year cohort study of outcome and potential predictors. Int J Geriatr Psychiatry 21 (1): 57-63.
8. Bonetti PO, Lerman LO, Lerman A,. 2003. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23 (2): 168-175.
9. Bots ML, van Swieten JC, Breteler MM, et al,. 1993. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 341 (8855): 1232-1237.
10. Butters MA, Bhalla RK, Mulsant BH, et al,. 2004. Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship? Am J Geriatr Psychiatry 12 (4): 387-394.
11. Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M,. 2010. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther 16 (5): 322-325.
12. Chen CS, Chen CC, Kuo YT, Chiang IC, Ko CH, Lin HF,. 2006. Carotid intima-media thickness in late-onset major depressive disorder. Int J Geriatr Psychiatry 21 (1): 36-42.
13. Cole MG, Bellavance F, Mansour A,. 1999. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry 156 (8): 1182-1189.
14. Culang-Reinlieb ME, Johnert LC, Brickman AM, et al,. 2010. MRI-defined vascular depression: a review of the construct. Int J Geriatr Psychiatry. DOI: 10.1002/gps.2668
15. Di Napoli M, Papa F,. 2005. C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology? Circulation 112 (6): 781-785.
16. Fava M,. 2003. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53 (8): 649-659.
17. Furberg CD, Adams HP Jr., Applegate WB, et al,. 1994. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 90 (4): 1679-1687.
18. Greenstein AS, Paranthaman R, Burns A, et al,. 2010. Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries. Hypertension 56 (4): 734-740.
19. Gunning-Dixon FM, Walton M, Cheng J, et al,. 2010. MRI signal hyperintensities and treatment remission of geriatric depression. J Affect Disord 126 (3): 395-401.
20. Hickie I, Scott E, Mitchell P, et al,. 1995. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37 (3): 151-160.
21. Janssen J, Hulshoff Pol HE, Schnack HG, et al,. 2007. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatry 22 (5): 468-474.
22. Krishnan KR, Hays JC, George LK, Blazer DG,. 1998. Six-month outcomes for MRI-related vascular depression. Depress Anxiety 8 (4): 142-146.
23. Malik RA, Schofield IJ, Izzard A, et al,. 2005. Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. Hypertension 45 (2): 264-269.
24. Naish JH, Baldwin RC, Patankar T, et al,. 2006. Abnormalities of CSF flow patterns in the cerebral aqueduct in treatment-resistant late-life depression: a potential biomarker of microvascular angiopathy. Magn Reson Med 56 (3): 509-516.
25. Paranthaman R, Greenstein AS, Burns AS, et al,. 2010. Vascular function in older adults with depressive disorder. Biol Psychiatry 68 (2): 133-139.
26. Patankar TF, Baldwin R, Mitra D, et al,. 2007. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord 97 (1-3): 265-270.
27. Petersen T, Papakostas GI, Posternak MA, et al,. 2005. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol 25 (4): 336-341.
28. Saghafi R, Brown C, Butters MA, et al,. 2007. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry 22 (11): 1141-1146.
29. Serebruany VL, Suckow RF, Cooper TB, et al,. 2005. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 162 (6): 1165-1170.
30. Sheline YI, Pieper CF, Barch DM, et al,. 2010. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 67 (3): 277-285.
31. Simpson S, Baldwin RC, Jackson A, Burns AS,. 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 28 (5): 1015-1026.
32. Taragano FE, Bagnatti P, Allegri RF,. 2005. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression". Int Psychogeriatr 17 (3): 487-498.
33. Taylor WD, Steffens DC, MacFall JR, et al,. 2003. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 60: 1090-1096.
34. Thase ME, Rush AJ,. 1995. Psychopharmacology: The Fourth Generation of Progress, 4th edn. Raven Press: New York.
35. Tiemeier H, van Dijck W, Hofman A, et al,. 2004. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry 61 (4): 369-376.
36. van Zyl LT, Lesperance F, Frasure-Smith N, et al,. 2009. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis 27 (1): 48-56.
37. World Health Organisation WHO. 1992. ICD-10 Classification of Mental and Behavioural Disorders. WHO: Geneva.